Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.

Stinnett AA, Mullahy J.

Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S68-80.

PMID:
9566468
2.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

3.

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

Briggs AH, Wonderling DE, Mooney CZ.

Health Econ. 1997 Jul-Aug;6(4):327-40. Review.

PMID:
9285227
4.

A note on confidence intervals in cost-effectiveness analysis.

Tambour M, Zethraeus N, Johannesson M.

Int J Technol Assess Health Care. 1998 Summer;14(3):467-71.

PMID:
9780533
5.

Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies.

Zethraeus N, Johannesson M, Jönsson B, Löthgren M, Tambour M.

Pharmacoeconomics. 2003;21(1):39-48. Review.

PMID:
12484802
6.

Cost-effectiveness analysis for clinicians.

Hill SR.

BMC Med. 2012 Feb 1;10:10. doi: 10.1186/1741-7015-10-10.

7.

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.

Briggs A, Fenn P.

Health Econ. 1998 Dec;7(8):723-40.

PMID:
9890333
8.

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

Willan AR, O'Brien BJ.

Health Econ. 1996 Jul-Aug;5(4):297-305. Erratum in: Health Econ 1999 Sep;8(6):559.

PMID:
8880166
9.

Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.

Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM.

Health Technol Assess. 2014 Sep;18(59):1-120. doi: 10.3310/hta18590. Review.

10.
11.

[The handling of uncertainty in economic evaluations of health care strategies].

Siani C, Moatti JP.

Rev Epidemiol Sante Publique. 2003 Apr;51(2):255-76. Review. French.

PMID:
12876511
12.
13.

Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results.

Tambour M, Zethraeus N.

Health Econ. 1998 Mar;7(2):143-7.

PMID:
9565170
14.

Bootstrapping: estimating confidence intervals for cost-effectiveness ratios.

Campbell MK, Torgerson DJ.

QJM. 1999 Mar;92(3):177-82. Review.

PMID:
10326078
15.

Representing uncertainty: the role of cost-effectiveness acceptability curves.

Fenwick E, Claxton K, Sculpher M.

Health Econ. 2001 Dec;10(8):779-87.

PMID:
11747057
16.

Opportunity costs and uncertainty in the economic evaluation of health care interventions.

Sendi P, Gafni A, Birch S.

Health Econ. 2002 Jan;11(1):23-31.

PMID:
11788979
17.

Stochastic league tables: an application to diabetes interventions in the Netherlands.

Hutubessy RC, Niessen LW, Dijkstra RF, Casparie TF, Rutten FF.

Health Econ. 2005 May;14(5):445-55.

PMID:
15386648
18.

Cost-effectiveness league tables: valuable guidance for decision makers?

Mauskopf J, Rutten F, Schonfeld W.

Pharmacoeconomics. 2003;21(14):991-1000.

PMID:
13129413
19.

Handling uncertainty when performing economic evaluation of healthcare interventions.

Briggs AH, Gray AM.

Health Technol Assess. 1999;3(2):1-134. No abstract available.

20.

Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.

Stinnett AA, Paltiel AD.

Med Decis Making. 1997 Oct-Dec;17(4):483-9.

PMID:
9343807

Supplemental Content

Support Center